Initial Safety and Tumor Control Results from a “First-in-Human” Multicenter Prospective Trial Evaluating a Novel Alpha-Emitting Radionuclide for the Treatment of Locally Advanced Recurrent Squamous Cell Carcinomas of the Skin and Head and Neck
To report the feasibility and safety of Diffusing Alpha-emitter Radiation Therapy (DaRT), which entails the interstitial implantation of a novel alpha-emitting brachytherapy source, for the treatment of locally advanced and recurrent squamous cancers (SCC) of the skin and head and neck.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: A. Popovtzer, E. Rosenfeld, A. Mizrachi, S.R. Bellia, R. Ben-Hur, G. Feliciani, A. Sarnelli, L. Arazi, L. Deutsch, I. Kelson, Y. Keisari Source Type: research
More News: Biology | Brachytherapy | Cancer | Cancer & Oncology | Carcinoma | Head and Neck Cancer | Physics | Radiation Therapy | Radiology | Skin | Squamous Cell Carcinoma